Skip to main navigation
logologo
  • About Us
    • Our Story
    • Message From CEO
    • Leadership Team
    • Board Members
    • Guiding Principles
    • Join Us
  • Our Science
    • Our Approach
    • Our Focus
      • MZL/FL
      • CLL
      • MS
    • Collaborate with Us
    • Meet With TG Medical
  • Our Products
  • Our Pipeline
    • Overview
    • Umbralisib
    • Ublituximab
    • TG-1501
    • TG-1701
    • TG-1801
  • Our Publications
  • Our Trials
    • Trial Information
    • Expanded Access Policy
  • Investors & Media
    • Press Releases
    • Stock Information
      • Historic Stock Lookup
    • SEC Filings & Financials
      • Quarterly Results
      • Annual Reports
      • SEC Filings
    • Events
    • IR & Media Contact
    • Management Team
    • Corporate Governance
    • FAQs
  • CAREERS
  • CONTACT US
  • Twitter
logo
Close
  • About Us
    • Our Story
    • Message From CEO
    • Leadership Team
    • Board Members
    • Guiding Principles
    • Join Us
  • Our Science
    • Our Approach
    • Our Focus
      • MZL/FL
      • CLL
      • MS
    • Collaborate with Us
    • Meet With TG Medical
  • Our Products
  • Our Pipeline
    • Overview
    • Umbralisib
    • Ublituximab
    • TG-1501
    • TG-1701
    • TG-1801
  • Our Publications
  • Our Trials
    • Trial Information
    • Expanded Access Policy
  • Investors & Media
    • Press Releases
    • Stock Information
      • Historic Stock Lookup
    • SEC Filings & Financials
      • Quarterly Results
      • Annual Reports
      • SEC Filings
    • Events
    • IR & Media Contact
    • Management Team
    • Corporate Governance
    • FAQs
Banner Image Banner Image

Investors
& Media

Annual Reports

Annual Reports

Title
2020 Annual Report
2019 Annual Report
2018 Annual Report
2017 Annual Report
2016 Annual Report
2015 Annual Report
2014 Annual Report
2013 Annual Report
2012 Annual Report
Email Alerts
RSS News Feeds
Print Page
Share facebook linkedin twitter
Search
Component-5-–-2

Email Us 1-877-575-TGTX (8489)

TG Therapeutics © . All rights reserved.

  • Join us
  • Contact Us
  • Privacy Policy
  • Terms of Use